OdySight mobile app reliably measures visual acuity in retina patients at home

Tilak Healthcare has released positive data from its TIL002 study of the OdySight mobile app, a vision-monitoring tool for patients with retinal diseases.
“TIL002 marks a key step in the clinical validation of OdySight and proves that it is a reliable way for patients to monitor their visual acuity by themselves at home,” Jean-François Girmens, MD, Tilak’s medical director and co-founder, said in a company press release. “In addition, given the variability of visual acuity measurements, having a large number of results from regular home tests could prove more helpful

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart